4.7 Article

Validation of the Pathogenic Effect of IGHMBP2 Gene Mutations Based on Yeast S. cerevisiae Model

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects

Caley E. Smith et al.

Summary: This study describes a new mouse model of SMARD1, which mimics the characteristics of the disease such as motor neuron degeneration and muscle atrophy. The disease phenotype, including respiratory defects, can be significantly alleviated by gene therapy.

HUMAN MOLECULAR GENETICS (2022)

Article Biochemistry & Molecular Biology

Mutations in GDAP1 Influence Structure and Function of the Trans-Golgi Network

Katarzyna Binieda et al.

Summary: Charcot-Marie-Tooth disease (CMT) is a heritable neurodegenerative disease with great genetic heterogeneity, and the molecular pathogenesis of most CMT subtypes remains unknown. This study identified mutations in the GDAP1 gene that disrupt the Golgi apparatus, leading to potential new treatment options for CMT disorders. The study also highlighted the role of the Golgi apparatus in the pathology of CMT diseases, providing insights for future translational research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

The GTPase Arf1 Is a Determinant of Yeast Vps13 Localization to the Golgi Apparatus

Damian Kolakowski et al.

Summary: This study used a yeast model to investigate the interaction between Vps13 and Golgi membrane, revealing a cooperation between Vps13 and Arf1 proteins at the Golgi apparatus. The C-terminal Pleckstrin homology (PH)-like domain of Vps13 binds to Arf1 GTPase and phosphoinositol 4,5-bisphosphate, determining the localization of VPS13 proteins to Golgi structures in yeast and humans.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Genetics & Heredity

The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases

Camilla Ceccatelli Berti et al.

Summary: The yeast Saccharomyces cerevisiae is an excellent model system for studying mitochondrial diseases, offering advantages in validating and characterizing new mutations, dissecting gene functionality related to mitochondria, and discovering potential therapeutic molecules. Studies on this simple eukaryotic organism have contributed significantly to the understanding of mitochondrial diseases.

GENES (2021)

Review Clinical Neurology

Models for IGHMBP2-associated diseases: an overview and a roadmap for the future

Weronika Rzepnikowska et al.

Summary: Disease models are crucial for studying the basic aspects and pathomechanisms of diseases, including enigmatic proteins like IGHMBP2. The role of IGHMBP2 in cellular processes remains poorly understood, with mutations potentially leading to specific neuronal disorders such as SMARD1 and CMT2S. Additional research is needed to fully elucidate the function and implications of IGHMBP2 mutations in disease progression.

NEUROMUSCULAR DISORDERS (2021)

Article Genetics & Heredity

Pathogenic Effect of GDAP1 Gene Mutations in a Yeast Model

Weronika Rzepnikowska et al.

GENES (2020)

Review Biochemistry & Molecular Biology

A Yeast-Based Model for Hereditary Motor and Sensory Neuropathies: A Simple System for Complex, Heterogeneous Diseases

Weronika Rzepnikowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Clinical Neurology

Spinal muscular atrophy with respiratory distress type 1: A multicenter retrospective study

Agnes Viguier et al.

NEUROMUSCULAR DISORDERS (2019)

Article Clinical Neurology

IGHMBP2 mutation associated with organ-specific autonomic dysfunction

Pedro J. Tomaselli et al.

NEUROMUSCULAR DISORDERS (2018)

Article Multidisciplinary Sciences

Elesclomol restores mitochondrial function in genetic models of copper deficiency

Shivatheja Soma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

UPF1-like helicase grip on nucleic acids dictates processivity

Joanne Kanaan et al.

NATURE COMMUNICATIONS (2018)

Article Clinical Neurology

Charcot Marie Tooth disease type 2S with late onset diaphragmatic weakness: An atypical case

Richa Kulshrestha et al.

NEUROMUSCULAR DISORDERS (2018)

Article Clinical Neurology

Genetic heterogeneity of motor neuropathies

Boglarka Bansagi et al.

NEUROLOGY (2017)

Article Cell Biology

Doa1 targets ubiquitinated substrates for mitochondria-associated degradation

Xi Wu et al.

JOURNAL OF CELL BIOLOGY (2016)

Article Clinical Neurology

Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2

Christeen Ramane J. Pedurupillay et al.

NEUROMUSCULAR DISORDERS (2016)

Review Cell Biology

The Ccr4-Not complex is a key regulator of eukaryotic gene expression

Martine A. Collart

WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)

Article Biochemistry & Molecular Biology

Rbs1, a New Protein Implicated in RNA Polymerase III Biogenesis in Yeast Saccharomyces cerevisiae

Malgorzata Ciesla et al.

MOLECULAR AND CELLULAR BIOLOGY (2015)

Article Clinical Neurology

Growing up with spinal muscular atrophy with respiratory distress (SMARD1)

Mark James Hamilton et al.

NEUROMUSCULAR DISORDERS (2015)

Article Clinical Neurology

Autosomal recessive axonal polyneuropathy in a sibling pair due to a novel homozygous mutation in IGHMBP2

Justin D. Wagner et al.

NEUROMUSCULAR DISORDERS (2015)

Article Genetics & Heredity

Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2

Ellen Cottenie et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2014)

Article Clinical Neurology

Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells

Maria Jedrzejowska et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2014)

Review Cell Biology

The Benefits of Humanized Yeast Models to Study Parkinson's Disease

V. Franssens et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Article Multidisciplinary Sciences

Yeast Reveal a Druggable Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Daniel F. Tardiff et al.

SCIENCE (2013)

Article Biochemistry & Molecular Biology

The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1

Siew Choo Lim et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Biochemistry & Molecular Biology

Modeling Huntington disease in yeast: Perspectives and future directions

Robert P. Mason et al.

Prion (2012)

Article Biochemistry & Molecular Biology

Maf1 Protein, Repressor of RNA Polymerase III, Indirectly Affects tRNA Processing

Iwona Karkusiewicz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Clinical Neurology

Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man

Tyler Mark Pierson et al.

NEUROMUSCULAR DISORDERS (2011)

Article Biochemistry & Molecular Biology

Chlorophenol stress affects aromatic amino acid biosynthesis - a genome-wide study

Vikas Yadav et al.

YEAST (2011)

Article Genetics & Heredity

Functional Evaluation of Paraplegin Mutations by a Yeast Complementation Assay

Florian Bonn et al.

HUMAN MUTATION (2010)

Article Biochemistry & Molecular Biology

IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)

Ulf-Peter Guenther et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery

Mariangels de Planell-Saguer et al.

HUMAN MOLECULAR GENETICS (2009)

Article Clinical Neurology

Interfamilial phenotypic heterogeneity in SMARD1

S. Joseph et al.

NEUROMUSCULAR DISORDERS (2009)

Article Clinical Neurology

Mutation of gene in spinal muscular atrophy respiratory distress type I

Virginia C. N. Wong et al.

PEDIATRIC NEUROLOGY (2006)

Article Genetics & Heredity

Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1

UP Guenther et al.

HUMAN GENETICS (2004)

Article Clinical Neurology

Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)

K Grohmann et al.

ANNALS OF NEUROLOGY (2003)

Article Biochemistry & Molecular Biology

Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae

K Pluta et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)

Article Biochemistry & Molecular Biology

FAP1, a homologue of human transcription factor NF-X1, competes with rapamycin for binding to FKBP12 in yeast

J Kunz et al.

MOLECULAR MICROBIOLOGY (2000)